Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Exenatide 2mg/0.85ml prolonged-release suspension for injection pre-filled disposable devices |
BNF code | 0601023Y0AAAEAE |
Virtual Therapeutic Moiety | Exenatide |
Abbreviated name | Exenatide 2mg/0.85ml prolonged-release inj pf dispos dev |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 0.850 |
Unit dose form units | ml |
Unit dose unit of measure | pre-filled disposable injection |
Virtual Product Ingredient | |
---|---|
Ingredient | Exenatide |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 2.353 |
Strength value numerator unit | mg |
Strength value denominator | 1.000 |
Strength value denominator unit | ml |
Ontology Drug Form & Route | |
Form & Route | suspensioninjectionprolonged-release.subcutaneous |
Dose Form | |
Formulation | Prolonged-release suspension for injection |
Drug Route | |
Route | Subcutaneous |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Bydureon BCise 2mg/0.85ml prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) | |
Virtual Medicinal Product Packs | |
Exenatide 2mg/0.85ml prolonged-release suspension for injection pre-filled disposable devices 4 pre-filled disposable injection |
dm+d data retrieved from TRUD: release NHSBSA_3.3.0_20250324000001, imported on 25th March 2025 at 04:09:19.